Trial Profile
Evaluation of the efficacy and prediction of the visual prognosis concerning intravitreal injection of aflibercept for retinal vein occlusion
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2018
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Retinal vein occlusion
- Focus Therapeutic Use
- 17 Sep 2014 New trial record